{"id":"W3192759045","doi":"10.1200/jco.21.00443","title":"Phase I Study of Venetoclax Plus Daratumumab and Dexamethasone, With or Without Bortezomib, in Patients With Relapsed or Refractory Multiple Myeloma With and Without t(11;14)","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Daratumumab; Venetoclax; Multiple myeloma; Refractory (planetary science); Phases of clinical research; Clinical trial; Salvage therapy; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001038952,0.0008926751,0.001447047,0.0003244792,0.000322285,0.0009074425,0.0007277806,0.0007591983,0.003244353],"category_scores_gemma":[0.000756146,0.0005151542,0.001009556,0.000433547,0.0009271685,0.00062408,0.0002884651,0.002257189,0.0005952377],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007946293,"about_ca_system_score_gemma":0.001364182,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007005358,"about_ca_topic_score_gemma":0.001927434,"domain_scores_codex":[0.9996827,0.0001365482,0.00001923302,0.00006932765,0.00003096718,0.00006136458],"domain_scores_gemma":[0.9993462,0.00009232502,0.000144134,0.00006000775,0.00003157558,0.0003257092],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7761105,0.07498078,0.008157076,0.0008327426,0.001560076,0.0002510016,0.0003083191,0.002498483,0.04539862,0.0002955055,0.002319891,0.08728693],"study_design_scores_gemma":[0.4530295,0.531229,0.00909734,0.0000399966,0.0003680479,0.0002385002,0.00004877491,0.0006632517,0.002832926,0.0001046224,0.002328569,0.00001951488],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9942117,0.001882799,0.0003472811,0.0002293869,0.0001021685,0.001433651,0.0005785791,0.00005005955,0.001164304],"genre_scores_gemma":[0.9937887,0.001241368,0.001037847,0.0004245195,0.0001261626,0.0008912685,0.001055429,0.00001306925,0.001421724],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003244353,"threshold_uncertainty_score":0.01085341,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1062274226056045,"score_gpt":0.459771776513919,"score_spread":0.3535443539083145,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}